- Home
- TPVG vs ETON Comparison
TPVG vs ETON Comparison
Compare TPVG & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPVG
- ETON
- Stock Information
- Founded
- TPVG 2013
- ETON 2017
- Country
- TPVG United States
- ETON United States
- Employees
- TPVG N/A
- ETON N/A
- Industry
- TPVG Other Consumer Services
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- TPVG Consumer Discretionary
- ETON Health Care
- Exchange
- TPVG Nasdaq
- ETON Nasdaq
- Market Cap
- TPVG 286.6M
- ETON 329.8M
- IPO Year
- TPVG N/A
- ETON 2018
- Fundamental
- Price
- TPVG $6.75
- ETON $12.50
- Analyst Decision
- TPVG Hold
- ETON Strong Buy
- Analyst Count
- TPVG 5
- ETON 3
- Target Price
- TPVG $7.31
- ETON $27.67
- AVG Volume (30 Days)
- TPVG 312.6K
- ETON 222.5K
- Earning Date
- TPVG 04-30-2025
- ETON 05-08-2025
- Dividend Yield
- TPVG 17.78%
- ETON N/A
- EPS Growth
- TPVG N/A
- ETON N/A
- EPS
- TPVG 0.82
- ETON N/A
- Revenue
- TPVG $108,208,000.00
- ETON $39,011,000.00
- Revenue This Year
- TPVG N/A
- ETON $92.33
- Revenue Next Year
- TPVG $5.11
- ETON $52.62
- P/E Ratio
- TPVG $8.24
- ETON N/A
- Revenue Growth
- TPVG N/A
- ETON 23.29
- 52 Week Low
- TPVG $6.44
- ETON $3.03
- 52 Week High
- TPVG $9.73
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- TPVG 27.74
- ETON 36.53
- Support Level
- TPVG $6.90
- ETON $12.24
- Resistance Level
- TPVG $7.20
- ETON $13.46
- Average True Range (ATR)
- TPVG 0.14
- ETON 0.94
- MACD
- TPVG -0.02
- ETON -0.15
- Stochastic Oscillator
- TPVG 3.64
- ETON 10.03
About TPVG TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the operations of the firm function through the region of the United states.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.